版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、河北大學碩士學位論文氫溴酸右美沙芬胃漂浮緩釋片的研制姓名:李莉申請學位級別:碩士專業(yè):藥物分析學指導教師:胡連棟2011-06Abstract II Abstract The floating drug delivery systems designed on the basis of hydrodynamically balanced system, which enable prolonged and continuous inpu
2、t of the drug to the upper parts of the gastrointestinal tract and improve the bioavailability of medications that are characterized by a narrow absorption window. A new strategy is proposed for the development of gastro
3、retentive dosage forms for dextromethorphan hydrobromide (DMB) preferably once daily. The design of the delivery system was based on the sustained release formulation, with floating and swelling features in order to prol
4、ong the gastric retention time, reduce the dosage frequency and increase patient compliance. According to the literature, ultraviolet spectrotometry method was developed for determination the release of DMB during the st
5、udy of in vitro release. High performance liquid chrmatograhy (HPLC) method was developed for assaying the content of DMB in the DMB sustained-release (SR) floating tablet. The analytical methods above were proved to be
6、simple, reliable and sensitive. In the floating test, different concentrations of hydrochloric acid solution (pH 1.2, 3.0, 5.0) were used as floating medium. The floating lag time and the total floating time were selecet
7、ed as determination index. These researches provide a reliable basis for the next formulation study and stability study. Basing on the preformulation study, influence of formulation and manufacture on the drug release an
8、d floating characteristics was investicated and an orthogonal experiment design method was used to select the optimized formulation. The optimized tablets were prepared by wet granulation method using hydroxypropyl methy
9、lcellulose (HPMC) K4M as hydrocolloid gelling agent (25 mg), sodium bicarbonate as gas-generating agent (20 mg), hexadecanol as floating assistant agent (18 mg), microcrystalline cellulose (MCC) and lactose as bulking ag
10、ent, 4% ethanol solution of ethylcellulose (w/v) as binding agent. The prepared tablets could float within 3min and maintain for more than 24 h. Drug release at 12 h was more than 85%.The data of physical parameters like
11、 weight, hardness, friability and drug content were all lie within the limits. The release mechanism of DMB was studied by comparing with Zero-order Model, First-order Model, Higuchi Model, Hixson-Crowell Model and Ritg
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 氫溴酸右美沙芬凝膠骨架緩釋片的研制.pdf
- 探討氫溴酸右美沙芬緩釋片的制備工藝及其釋放度
- 氫溴酸右美沙芬糖漿
- 星點設(shè)計-效應(yīng)面法優(yōu)化氫溴酸右美沙芬胃漂浮微球工藝.pdf
- 胃康漂浮緩釋片的研制.pdf
- 戊己胃漂浮緩釋片的研制.pdf
- 胃漂浮滯留緩釋片的漂浮機理研究
- 氫溴酸右美沙芬控釋(小丸)膠囊的穩(wěn)定性研究
- 高效液相色譜法測定人血中氫溴酸右美沙芬濃度
- 間尼索地平胃內(nèi)漂浮型緩釋片的研制.pdf
- 鹽酸二甲雙胍胃漂浮緩釋片的研制.pdf
- 馬來酸曲美布汀胃漂浮緩釋片的實驗研究.pdf
- 雙苯氟嗪胃內(nèi)滯留漂浮型緩釋片的研制.pdf
- 蒲元胃內(nèi)漂浮緩釋片的藥學研究.pdf
- 元胡止痛胃內(nèi)漂浮緩釋片的藥學研究.pdf
- 復(fù)方白芨胃內(nèi)滯留漂浮型緩釋片的研究.pdf
- 厄貝沙坦緩釋片的研制.pdf
- 氫溴酸加蘭他敏緩釋片的藥學研究及藥動學評價.pdf
- 鹽酸左旋沙丁胺醇緩釋片的研制.pdf
- TFH緩釋片的研制.pdf
評論
0/150
提交評論